Clinical trial
Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye
NCT01521507 is registered in ClinicalTrials.gov with TearScience, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye
- Lead sponsor
- TearScience, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- January 31, 2014
- Enrollment
- 200 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye, meibomian gland dysfunction